| Literature DB >> 23419172 |
Salma Jamal1, Vinita Periwal, Vinod Scaria.
Abstract
BACKGROUND: Malaria is a major healthcare problem worldwide resulting in an estimated 0.65 million deaths every year. It is caused by the members of the parasite genus Plasmodium. The current therapeutic options for malaria are limited to a few classes of molecules, and are fast shrinking due to the emergence of widespread resistance to drugs in the pathogen. The recent availability of high-throughput phenotypic screen datasets for antimalarial activity offers a possibility to create computational models for bioactivity based on chemical descriptors of molecules with potential to accelerate drug discovery for malaria.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23419172 PMCID: PMC3599641 DOI: 10.1186/1471-2105-14-55
Source DB: PubMed Journal: BMC Bioinformatics ISSN: 1471-2105 Impact factor: 3.169
Classification results
| 41.8 | 21.4 | 78.6 | 58.2 | 65.1 | 74.81 | 59.5 | 2 | |
| 51 | 20.9 | 79.1 | 49 | 70.8 | 76.27 | 64 | 40 | |
| 44.6 | 21.1 | 78.9 | 55.4 | 62.3 | 75.38 | 61 | 9 |
*CSC denotes CostSensitiveClassifier,#Balanced Classification Rate.
Figure 1Comparison of accuracy and balanced classification rate.
Figure 2Plot of sensitivity and specificity.
Figure 3ROC plot depicting significant AUC curve values for Random Forest, Naïve Bayes and J48.
Significantly enriched scaffolds in the active dataset
| Scaffold 1 | 21 | 4 | 8.52 | 3.51E-03 | 46.39 | |
| Scaffold 2 | 4 | 1 | 26.70 | 2.37E-07 | 35.34 | |
| Scaffold 3 | 25 | 17 | 23.61 | 1.18E-06 | 12.99 | |
| Scaffold 4 | 7 | 7 | 12.78 | 3.49E-04 | 8.83 | |
| Scaffold 5 | 2 | 2 | 11.75 | 6.07E-04 | 8.83 | |
| Scaffold 6 | 2 | 2 | 6.95 | 8.38E-03 | 8.83 | |
| Scaffold 7 | 95 | 166 | 196.90 | 9.88E-45 | 5.05 | |
| Scaffold 8 | 6 | 11 | 17.67 | 2.62E-05 | 4.82 | |
| Scaffold 9 | 43 | 80 | 82.84 | 8.89E-20 | 4.74 | |
| Scaffold 10 | 24 | 54 | 36.26 | 1.72E-09 | 3.92 | |
| Scaffold 11 | 4 | 9 | 6.04 | 1.40E-02 | 3.92 | |
| Scaffold 12 | 22 | 54 | 29.36 | 5.99E-08 | 3.60 | |
| Scaffold 13 | 201 | 570 | 241.30 | 1.58E-48 | 3.11 | |
| Scaffold 14 | 10 | 29 | 10.48 | 1.20E-03 | 3.04 | |
| Scaffold 15 | 134 | 392 | 135.32 | 2.81E-31 | 3.02 | |
| Scaffold 16 | 9 | 31 | 6.66 | 9.83E-03 | 2.56 | |
| Scaffold 17 | 48 | 181 | 29.25 | 6.36E-08 | 2.34 | |
| Scaffold 18 | 126 | 488 | 72.29 | 1.85E-17 | 2.28 | |
| Scaffold 19 | 41 | 178 | 17.57 | 2.77E-05 | 2.03 | |
| Scaffold 20 | 164 | 722 | 67.82 | 1.79E-16 | 2.00 |
Figure 4Molecular overlay. Alignment of 20 enriched scaffolds (dark green) with top 20 compounds of active dataset. Ranking was obtained from their Tanimoto similarity and overlap with the reference scaffold.